about
Correlations among brain gray matter volumes, age, gender, and hemisphere in healthy individualsNeural Alterations in Acquired Age-Related Hearing Loss.Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseWhite matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies.Effective artifact removal in resting state fMRI data improves detection of DMN functional connectivity alteration in Alzheimer's disease.Brain imaging in dementia.Assessing Relevance of External Cognitive MeasuresNeuro-degeneration profile of Alzheimer's patients: A brain morphometry studyDorsal visual pathway changes in patients with comitant extropia.Remote sites of structural atrophy predict later amyloid formation in a mouse model of Alzheimer's disease.Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals.Brain MR Image Classification for Alzheimer's Disease Diagnosis Based on Multifeature Fusion.Diagnosis and biomarkers of predementia in Alzheimer's disease.The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques.Association between income and the hippocampus.Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer's diseaseNeuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications.Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease.Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysisVoxel-based meta-analysis of grey matter changes in Alzheimer's disease.Mapping the structural brain changes in Alzheimer's disease: the independent contribution of two imaging modalities.Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer's disease: a voxel-based morphometry study.Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.Using Voxel-Based Morphometry to Examine the Relationship between Regional Brain Volumes and Memory Performance in Amnestic Mild Cognitive ImpairmentA combined electrophysiological and morphological examination of episodic memory decline in amnestic mild cognitive impairment.Neuroinflammation and brain functional disconnection in Alzheimer's disease.Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly.Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience.Gray matter atrophy in behavioral variant frontotemporal dementia: a meta-analysis of voxel-based morphometry studies.Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.Is DARTEL-based voxel-based morphometry affected by width of smoothing kernel and group size? A study using simulated atrophy.Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.Selecting the most relevant brain regions to discriminate Alzheimer's disease patients from healthy controls using multiple kernel learning: A comparison across functional and structural imaging modalities and atlases.Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.Multimodal Voxel-Based Meta-Analysis of White Matter Abnormalities in Alzheimer's Disease.A longitudinal study of age- and gender-related annual rate of volume changes in regional gray matter in healthy adults.Support vector machine-based classification of neuroimages in Alzheimer's disease: direct comparison of FDG-PET, rCBF-SPECT and MRI data acquired from the same individuals.Impaired and preserved aspects of feedback learning in aMCI: contributions of structural connectivity.Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele.What determines continuing grey matter changes in first-episode schizophrenia and affective psychosis?
P2860
Q21560940-9260F53A-6669-4CB0-807E-643CE7D9CD5AQ26745548-D0EE3DE8-B6D6-43E3-9443-5E83ADFCD5AAQ27027319-929A8D72-7742-454D-90EF-A2AA4EB70349Q30620060-C0A11D5F-0935-4653-A210-C8B7C7F22CA6Q30990756-718612B1-CFDD-4CB4-BE1E-00F2F28E0778Q31051218-D9B02022-9C4E-4D8E-87C1-221A1832DD70Q31172442-FB73E4B4-DDD1-43B1-B6C6-091F4ECE4D1EQ33581593-660CDB76-E94F-4639-9DB7-7CA3F85BA1B5Q33598448-02DFD9FA-47A1-40DB-A1BC-B6EF39E8C158Q33665060-C109A276-A4A8-4BE4-902A-84FD355199FFQ33759240-A9BAF09E-76B9-4EFA-AC42-8C7693219E8FQ33762542-1143E01B-A188-45A4-B3E0-540D451D23ABQ33777509-A331DBE8-0947-42C1-93AC-E1B1C135E7EFQ33875000-B24C840E-BC9D-49F2-8E07-432D7588CEE0Q33900913-55C71732-C5DA-4C3E-9173-C58D5A7D75F2Q33927545-B1CBED02-64E2-434D-A14C-2B9CC5E1547AQ33968419-80A895F5-3A23-4CEB-B309-4FF60565B478Q34030564-21AC7B9E-DA37-4C59-94D9-D85548C0D70EQ34393431-CABB5583-4AB8-4346-B75C-28B7EFB9140AQ35237938-3F9E158C-C448-4E02-A134-652DD2D0D093Q35703200-DFB8723F-1C4E-41C1-8F66-CC8B280430E3Q36498440-A3855DA2-DBAD-464B-9EE1-764B55D0BDF3Q36981538-7D940B8D-860F-4C7E-8E0A-2341DFD9295CQ37035442-A62D3E60-1F18-4B44-84F6-90A64320B423Q37189765-8C571B4B-5AB2-4F15-848D-9F97C7F2A0C3Q37338892-1A8F6A11-9E35-405C-B71B-61C17A5EC02AQ37389846-3881BEA0-D22D-43CA-8C45-28ACAE8E3251Q37721144-175219CD-DB6B-49A5-B04E-F7AF5924E1EBQ38020748-FD564628-64EA-49A7-BA42-9F3687A30522Q41458145-B993D1B7-DF12-4531-AECA-A4228AEF3E31Q44187195-B8211E7C-F4FF-4561-BDAC-2B1C5E067DCFQ45300839-B08EEA67-8E46-4B06-8C24-C39CBB25E2A9Q45943003-81D21B3A-AF23-4363-BBAE-FE36AD47C014Q45949141-C840CED8-FD7C-4B32-B150-9C28500AFA1FQ46081646-9F120B34-9C59-443D-896A-B0D7FCC801CBQ46894746-28D5CD68-60B8-4D0C-AC6E-E5B1F5023B89Q47184005-A90EC39F-FD64-4273-B372-ADCE1C9410F5Q48123935-D44FB198-BAA2-446C-B221-E264EEF33E09Q48429937-EC060100-7A9D-46C9-AA1E-7B6A13AE67F9Q48569172-7A99E146-4FD7-43CC-8FB3-96228AEEB8C5
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Voxel-based morphometry in Alzheimer's disease.
@ast
Voxel-based morphometry in Alzheimer's disease.
@en
type
label
Voxel-based morphometry in Alzheimer's disease.
@ast
Voxel-based morphometry in Alzheimer's disease.
@en
prefLabel
Voxel-based morphometry in Alzheimer's disease.
@ast
Voxel-based morphometry in Alzheimer's disease.
@en
P2860
P1476
Voxel-based morphometry in Alzheimer's disease.
@en
P2093
Marcus V Zanetti
P2860
P304
P356
10.1586/14737175.8.11.1691
P577
2008-11-01T00:00:00Z